NORML Responds To National Academy of Sciences' Marijuana Report
Washington, DC: The National Academy of Sciences, Engineering, and Medicine released a comprehensive report today acknowledging that "conclusive or substantial evidence" exists for cannabis' efficacy in patients suffering from chronic pain, and sharply criticized longstanding federal regulatory barriers to marijuana research – in particular "the classification of cannabis as a Schedule I substance" under federal law.
Authors of the report also addressed various aspects of marijuana's effect on health and safety, acknowledging that the substance may pose certain potential risks for adolescents, pregnant women, and for those who may be driving shortly after ingesting cannabis. In each of these cases, these risks may be mitigated via marijuana regulation and the imposition of age restrictions in the marketplace.
Commenting on the report, NORML Deputy Director Paul Armentano said:
"The National Academy of Science's conclusions that marijuana possesses established therapeutic utility for certain patients and that it possesses an acceptable safety profile when compared to those of other medications or recreational intoxicants are not surprising. This evidence has been available for some time, yet for decades marijuana policy in this country has largely been driven by rhetoric and emotion, not science and evidence.
"A search on PubMed, the repository for all peer-reviewed scientific papers, using the term 'marijuana' yields over 24,000 scientific papers referencing the plant or its biologically active constituents -- a far greater body of literature than exists for commonly consumed conventional drugs like Tylenol, ibuprofen, or hydrocodone. Further, unlike modern pharmaceuticals, cannabis possesses an extensive history of human use dating back thousands of years, thus providing society with ample empirical evidence as to its relative safety and efficacy.
"Today, 29 states and Washington, DC permit physicians to recommend marijuana therapy. Some of these state-sanctioned programs have now been in place for nearly two decades. Eight states also permit the regulated use and sale of cannabis by adults. At a minimum, we know enough about cannabis, as well as the failures of cannabis prohibition, to regulate its consumption by adults, end its longstanding criminalization, and to remove it from its Schedule I prohibitive under federal law."
The report marks the first time since 1999 that the National Academy of Sciences has addressed issues surrounding marijuana and health. Authors reviewed over 10,000 scientific abstracts in their preparation of the new report.
For more information, please contact Paul Armentano, NORML Deputy Director, at: firstname.lastname@example.org or Erik Altieri, NORML Executive Director, at (202) 483-5500.